(Q35708191)

9 August 2017

Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody (English)

1 reference

9 August 2017

0 references

Youle M

1

1 reference

9 August 2017

Clarbour J

2

1 reference

9 August 2017

Farthing C

3

1 reference

9 August 2017

Connolly M

4

1 reference

9 August 2017

Hawkins D

5

1 reference

9 August 2017

Staughton R

6

1 reference

9 August 2017

Gazzard B

7

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 1989

1 reference

9 August 2017

1 reference

9 August 2017

298

1 reference

9 August 2017

432

1 reference

9 August 2017

6671

1 reference

Thalidomide--effect on T cell subsets as a possible mechanism of action

9 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1835649

Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis

12 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2495052

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral manifestations in patients with AIDS or AIDS-related complex

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2495052

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Significant response of oral aphthosis to thalidomide treatment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2495052

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.298.6671.432

1 reference

9 August 2017

1 reference

9 August 2017

1 reference